Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

New compounds were made that are promising for prostate cancer therapy.

ART for HIV/AIDS can cause side effects but is crucial for managing the infection.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Pexidartinib often causes liver issues and fatigue, especially in women.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Most patients improved with oral contraceptives, but some needed additional treatment.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

More effective methods are needed to prevent hair loss from chemotherapy.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Higher concentrations of dithranol can help regrow hair in severe alopecia areata.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

New compounds may help treat prostate cancer by reducing cell growth.